Dan Goldstein Haemonetics Corp (HAE) insider trading activity

Dan Goldstein is VP, Corporate Controller of HAEMONETICS CORP. Currently has a direct ownership of 4,447 shares of HAE, which is worth approximately $377,639. The most recent transaction as insider was on Jun 13, 2022, when has been sold 42 shares (Common Stock) at a price of $62.6 per share, resulting in proceeds of $2,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.45K

0% 3M change

0% 12M change

Total Value Held $377,639

Dan Goldstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2022	SELL Open market or private sale	$2,629 $62.6 p/Share	42 Reduced 0.94%	4,447 Common Stock
Jun 02 2022	SELL Open market or private sale	$15,610 $62.69 p/Share	249 Reduced 5.26%	4,489 Common Stock
May 19 2022	SELL Open market or private sale	$7,919 $59.1 p/Share	134 Reduced 2.75%	4,738 Common Stock
May 16 2022	SELL Open market or private sale	$2,805 $56.1 p/Share	50 Reduced 1.23%	4,004 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	868 Added 15.12%	4,872 Common Stock
Jun 14 2021	SELL Open market or private sale	$2,335 $59.87 p/Share	39 Reduced 0.95%	4,054 Common Stock
Jun 07 2021	SELL Open market or private sale	$4,462 $55.09 p/Share	81 Reduced 1.94%	4,093 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	1,753 Added 29.58%	4,174 Common Stock
May 19 2021	SELL Open market or private sale	$2,318 $55.19 p/Share	42 Reduced 1.71%	2,421 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	994 Added 28.75%	2,463 Common Stock
May 17 2021	SELL Open market or private sale	$2,351 $55.97 p/Share	42 Reduced 2.78%	1,469 Common Stock
Feb 04 2021	SELL Open market or private sale	$363,042 $135.92 p/Share	2,671 Reduced 63.87%	1,511 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$183,083 $75.25 p/Share	2,433 Added 51.96%	2,249 Common Stock
Oct 26 2020	SELL Open market or private sale	$10,600 $106.0 p/Share	100 Reduced 5.41%	1,749 Common Stock

Dan Goldstein

VP, Corporate Controller

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account